We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Myriad Genetics
MYGN
$369M
| $3.38M | 0.01% |
122,329
+29,534
| +32% | +$856K |
|
927
Gray Television
GTN
$490M
| $3.36M | 0.01% |
166,593
+15,998
| +11% | +$354K |
|
|
UCB
928
United Community Banks
UCB
$4.2B
| $3.35M | 0.01% |
93,271
+174
| +0.2% | +$6.08K |
|
|
SYNH
929
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.35M | 0.01% |
32,644
-3,267
| -9% | -$314K |
|
930
First Commonwealth Financial
FCF
$2.14B
| $3.33M | 0.01% |
206,865
+704
| +0.3% | +$10.7K |
|
931
HCA Healthcare
HCA
$93.2B
| $3.33M | 0.01% |
12,953
-32
| -0.2% | -$7.83K |
|
932
Tennant Co
TNC
$1.16B
| $3.33M | 0.01% |
41,036
+1
| +0% | +$80 |
|
933
Bunge Global
BG
$22.5B
| $3.32M | 0.01% |
35,526
| – | – |
|
|
CIVI
934
DELISTED
Civitas Resources
CIVI
| $3.31M | 0.01% |
67,570
-28,813
| -30% | -$1.53M |
|
|
ELAT
935
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $3.3M | 0.01% |
73,991
| – | – |
|
936
RH
RH
$2.4B
| $3.29M | 0.01% |
6,141
-97
| -2% | -$59.7K |
|
937
Alaska Air
ALK
$4.43B
| $3.28M | 0.01% |
62,875
+58,175
| +1,238% | +$3.15M |
|
938
Nasdaq
NDAQ
$49.6B
| $3.25M | 0.01% |
46,386
-19,635
| -30% | -$1.34M |
|
939
Advanced Energy
AEIS
$10.1B
| $3.25M | 0.01% |
35,640
-1,125
| -3% | -$100K |
|
940
Neurocrine Biosciences
NBIX
$15.2B
| $3.21M | 0.01% |
37,680
-1,975
| -5% | -$182K |
|
941
Ashland
ASH
$3.23B
| $3.19M | 0.01% |
29,660
-872
| -3% | -$87.7K |
|
|
SF
942
Stifel
SF
$11.4B
| $3.17M | 0.01% |
67,538
-1,320
| -2% | -$64.1K |
|
943
NextCure
NXTC
$27.6M
| $3.15M | 0.01% |
43,795
-120
| -0.3% | -$10K |
|
944
Rivian
RIVN
$22.1B
| $3.15M | 0.01% |
+30,362
| New | +$3.5M |
|
945
Visteon
VC
$2.6B
| $3.15M | 0.01% |
28,298
-56
| -0.2% | -$6.22K |
|
946
Louisiana-Pacific
LPX
$4.57B
| $3.13M | 0.01% |
40,017
-2,235
| -5% | -$153K |
|
|
AEL
947
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.1M | 0.01% |
79,593
+282
| +0.4% | +$9.83K |
|
948
Builders FirstSource
BLDR
$6.42B
| $3.03M | 0.01% |
35,358
+1,348
| +4% | +$91.3K |
|
949
Public Storage
PSA
$55.1B
| $3.03M | 0.01% |
8,085
-385
| -5% | -$129K |
|
950
Cushman & Wakefield Ltd
CWK
$2.94B
| $3.01M | 0.01% |
135,394
+113,619
| +522% | +$2.2M |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.